Sleep, insomnia, and hypertension: current findings and future directions

Journal of the American Society of Hypertension

Volumn 11, Issue 2, 2017, Pages 122-129

  Thomas, S Justin ^a   Calhoun, David ^b  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b University of Alabama at Birmingham and Birmingham Veterans Affairs Medical Center   (United States)

Author keywords

Ambulatory blood pressure monitoring; hypertension; insomnia

Indexed keywords

BLOOD PRESSURE MONITORING; CONFOUNDING VARIABLE; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; HUMAN; HYPERTENSION; INSOMNIA; PRIORITY JOURNAL; REVIEW; SLEEP; SLEEP DEPRIVATION; SLEEP DISORDERED BREATHING; SLEEP QUALITY; SLEEP TIME; SYSTOLIC BLOOD PRESSURE; BLOOD PRESSURE; CLINICAL TRIAL (TOPIC); COMPLICATION; EPIDEMIOLOGY; PHYSIOLOGY; RISK FACTOR; TIME FACTOR;

BLOOD PRESSURE; BLOOD PRESSURE MONITORING, AMBULATORY; CLINICAL TRIALS AS TOPIC; CONFOUNDING FACTORS (EPIDEMIOLOGY); HUMANS; HYPERTENSION; RISK FACTORS; SLEEP; SLEEP APNEA, OBSTRUCTIVE; SLEEP DEPRIVATION; SLEEP INITIATION AND MAINTENANCE DISORDERS; TIME FACTORS;

EID: 85009812169     PISSN: 19331711     EISSN: 18787436     Source Type: Journal    
DOI: 10.1016/j.jash.2016.11.008     Document Type: Review

References (67)

1. 1 Pickering, T.G., Shimbo, D., Haas, D., Ambulatory blood-pressure monitoring. N Engl J Med 354:22 (2006), 2368–2374.
2. 2 Kario, K., Morning surge in blood pressure and cardiovascular risk: evidence and perspectives. Hypertension 56:5 (2010), 765–773.
3. 3 Goncharuk, V.D., Van Heerikhuize, J., Swaab, D.F., Buijs, R.M., Paraventricular nucleus of the human hypothalamus in primary hypertension: activation of corticotropin-releasing hormone neurons. J Comp Neurol 443:4 (2002), 321–331.
4. 4 Curtis, A.M., Cheng, Y., Kapoor, S., Reilly, D., Price, T.S., Fitzgerald, G.A., Circadian variation of blood pressure and the vascular response to asynchronous stress. Proc Natl Acad Sci U S A 104:9 (2007), 3450–3455.
5. 5 Stow, L.R., Richards, J., Cheng, K.Y., Lynch, I.J., Jeffers, L.A., Greenlee, M.M., et al. The circadian protein period 1 contributes to blood pressure control and coordinately regulates renal sodium transport genes. Hypertension 59:6 (2012), 1151–1156.
6. 6 Doi, M., Takahashi, Y., Komatsu, R., Yamazaki, F., Yamada, H., Haraguchi, S., et al. Salt-sensitive hypertension in circadian clock-deficient cry-null mice involves dysregulated adrenal Hsd3b6. Nat Med 16:1 (2010), 67–74.
7. 7 Zuber, A.M., Centeno, G., Pradervand, S., Nikolaeva, S., Maquelin, L., Cardinaux, L., et al. Molecular clock is involved in predictive circadian adjustment of renal function. Proc Natl Acad Sci U S A 106:38 (2009), 16523–16528.
8. 8 Scheer, F.A., Van Montfrans, G.A., van Someren, E.J., Mairuhu, G., Buijs, R.M., Daily nighttime melatonin reduces blood pressure in male patients with essential hypertension. Hypertension 43:2 (2004), 192–197.
9. 9 James, G.D., Pickering, T.G., The influence of behavioral factors on the daily variation of blood pressure. Am J Hypertens 6:6 Pt 2 (1993), 170S–173S.
10. 10 Ohkubo, T., Hozawa, A., Nagai, K., Kikuya, M., Tsuji, I., Ito, S., et al. Prediction of stroke by ambulatory blood pressure monitoring versus screening blood pressure measurements in a general population: the Ohasama study. J Hypertens 18:7 (2000), 847–854.
11. 11 Dolan, E., Stanton, A.V., Thom, S., Caulfield, M., Atkins, N., McInnes, G., et al. Ambulatory blood pressure monitoring predicts cardiovascular events in treated hypertensive patients–an Anglo-Scandinavian cardiac outcomes trial substudy. J Hypertens 27:4 (2009), 876–885.
12. 12 Kario, K., Pickering, T.G., Matsuo, T., Hoshide, S., Schwartz, J.E., Shimada, K., Stroke prognosis and abnormal nocturnal blood pressure falls in older hypertensives. Hypertension 38:4 (2001), 852–857.
13. 13 Ben-Dov, I.Z., Kark, J.D., Ben-Ishay, D., Mekler, J., Ben-Arie, L., Bursztyn, M., Blunted heart rate dip during sleep and all-cause mortality. Arch Intern Med 167:19 (2007), 2116–2121.
14. 14 Sherwood, A., Steffen, P.R., Blumenthal, J.A., Kuhn, C., Hinderliter, A.L., Nighttime blood pressure dipping: the role of the sympathetic nervous system. Am J Hypertens 15:2 Pt 1 (2002), 111–118.
15. 15 Kario, K., Shimada, K., Pickering, T.G., Abnormal nocturnal blood pressure falls in elderly hypertension: clinical significance and determinants. J Cardiovasc Pharmacol 41 Suppl 1 (2003), S61–S66.
16. 16 Zelinka, T., Strauch, B., Pecen, L., Widimsky, J. Jr., Diurnal blood pressure variation in pheochromocytoma, primary aldosteronism and Cushing's syndrome. J Hum Hypertens 18:2 (2004), 107–111.
17. 17 Hermida, R.C., Ayala, D.E., Fernandez, J.R., Portaluppi, F., Fabbian, F., Smolensky, M.H., Circadian rhythms in blood pressure regulation and optimization of hypertension treatment with ACE inhibitor and ARB medications. Am J Hypertens 24:4 (2011), 383–391.
18. 18 Uzu, T., Ishikawa, K., Fujii, T., Nakamura, S., Inenaga, T., Kimura, G., Sodium restriction shifts circadian rhythm of blood pressure from nondipper to dipper in essential hypertension. Circulation 96:6 (1997), 1859–1862.
19. 19 Fujii, T., Uzu, T., Nishimura, M., Takeji, M., Kuroda, S., Nakamura, S., et al. Circadian rhythm of natriuresis is disturbed in nondipper type of essential hypertension. Am J Kidney Dis 33:1 (1999), 29–35.
20. 20 Agarwal, R., Andersen, M.J., Prognostic importance of ambulatory blood pressure recordings in patients with chronic kidney disease. Kidney Int 69:7 (2006), 1175–1180.
21. 21 Fabbian, F., Smolensky, M.H., Tiseo, R., Pala, M., Manfredini, R., Portaluppi, F., Dipper and non-dipper blood pressure 24-hour patterns: circadian rhythm-dependent physiologic and pathophysiologic mechanisms. Chronobiol Int 30:1-2 (2013), 17–30.
22. 22 Sica, D.A., What are the influences of salt, potassium, the sympathetic nervous system, and the renin-angiotensin system on the circadian variation in blood pressure?. Blood Press Monit 4 Suppl 2 (1999), S9–S16.
23. 23 Somers, V.K., Dyken, M.E., Clary, M.P., Abboud, F.M., Sympathetic neural mechanisms in obstructive sleep apnea. J Clin Invest 96:4 (1995), 1897–1904.
24. 24 Narkiewicz, K., Pesek, C.A., Kato, M., Phillips, B.G., Davison, D.E., Somers, V.K., Baroreflex control of sympathetic nerve activity and heart rate in obstructive sleep apnea. Hypertension 32:6 (1998), 1039–1043.
25. 25 Narkiewicz, K., Kato, M., Phillips, B.G., Pesek, C.A., Davison, D.E., Somers, V.K., Nocturnal continuous positive airway pressure decreases daytime sympathetic traffic in obstructive sleep apnea. Circulation 100:23 (1999), 2332–2335.
26. 26 Conen, D., Bamberg, F., Noninvasive 24-h ambulatory blood pressure and cardiovascular disease: a systematic review and meta-analysis. J Hypertens 26:7 (2008), 1290–1299.
27. 27 Fan, H.Q., Li, Y., Thijs, L., Hansen, T.W., Boggia, J., Kikuya, M., et al. Prognostic value of isolated nocturnal hypertension on ambulatory measurement in 8711 individuals from 10 populations. J Hypertens 28:10 (2010), 2036–2045.
28. 28 Dolan, E., Stanton, A., Thijs, L., Hinedi, K., Atkins, N., McClory, S., et al. Superiority of ambulatory over clinic blood pressure measurement in predicting mortality: the Dublin outcome study. Hypertension 46:1 (2005), 156–161.
29. 29 Peppard, P.E., Young, T., Palta, M., Skatrud, J., Prospective study of the association between sleep-disordered breathing and hypertension. N Engl J Med 342:19 (2000), 1378–1384.
30. 30 O'Connor, G.T., Caffo, B., Newman, A.B., Quan, S.F., Rapoport, D.M., Redline, S., et al. Prospective study of sleep-disordered breathing and hypertension: the Sleep Heart Health Study. Am J Respir Crit Care Med 179:12 (2009), 1159–1164.
31. 31 Haentjens, P., Van Meerhaeghe, A., Moscariello, A., De Weerdt, S., Poppe, K., Dupont, A., et al. The impact of continuous positive airway pressure on blood pressure in patients with obstructive sleep apnea syndrome: evidence from a meta-analysis of placebo-controlled randomized trials. Arch Intern Med 167:8 (2007), 757–764.
32. 32 Lanfranchi, P.A., Pennestri, M.H., Fradette, L., Dumont, M., Morin, C.M., Montplaisir, J., Nighttime blood pressure in normotensive subjects with chronic insomnia: implications for cardiovascular risk. Sleep 32:6 (2009), 760–766.
33. 33 Vgontzas, A.N., Tsigos, C., Bixler, E.O., Stratakis, C.A., Zachman, K., Kales, A., et al. Chronic insomnia and activity of the stress system: a preliminary study. J Psychosom Res 45:1 (1998), 21–31.
34. 34 Gottlieb, D.J., Redline, S., Nieto, F.J., Baldwin, C.M., Newman, A.B., Resnick, H.E., et al. Association of usual sleep duration with hypertension: the Sleep Heart Health Study. Sleep 29:8 (2006), 1009–1014.
35. 35 Gangwisch, J.E., Heymsfield, S.B., Boden-Albala, B., Buijs, R.M., Kreier, F., Pickering, T.G., et al. Short sleep duration as a risk factor for hypertension: analyses of the first National Health and Nutrition Examination Survey. Hypertension 47:5 (2006), 833–839.
36. 36 Cappuccio, F.P., Stranges, S., Kandala, N.B., Miller, M.A., Taggart, F.M., Kumari, M., et al. Gender-specific associations of short sleep duration with prevalent and incident hypertension: the Whitehall II Study. Hypertension 50:4 (2007), 693–700.
37. 37 Kim, J., Jo, I., Age-dependent association between sleep duration and hypertension in the adult Korean population. Am J Hypertens 23:12 (2010), 1286–1291.
38. 38 Fang, J., Wheaton, A.G., Keenan, N.L., Greenlund, K.J., Perry, G.S., Croft, J.B., Association of sleep duration and hypertension among US adults varies by age and sex. Am J Hypertens 25:3 (2012), 335–341.
39. 39 Stranges, S., Dorn, J.M., Cappuccio, F.P., Donahue, R.P., Rafalson, L.B., Hovey, K.M., et al. A population-based study of reduced sleep duration and hypertension: the strongest association may be in premenopausal women. J Hypertens 28:5 (2010), 896–902.
40. 40 van den Berg, J.F., Tulen, J.H., Neven, A.K., Hofman, A., Miedema, H.M., Witteman, J.C., et al. Sleep duration and hypertension are not associated in the elderly. Hypertension 50:3 (2007), 585–589.
41. 41 Fiorentini, A., Valente, R., Perciaccante, A., Tubani, L., Sleep's quality disorders in patients with hypertension and type 2 diabetes mellitus. Int J Cardiol 114:2 (2007), E50–E52.
42. 42 Rod, N.H., Vahtera, J., Westerlund, H., Kivimaki, M., Zins, M., Goldberg, M., et al. Sleep disturbances and cause-specific mortality: Results from the GAZEL cohort study. Am J Epidemiol 173:3 (2011), 300–309.
43. 43 Bruno, R.M., Palagini, L., Gemignani, A., Virdis, A., DiGiulio, A., Ghiadoni, L., et al. Poor sleep quality and resistant hypertension. Sleep Med 14:11 (2013), 1157–1163.
44. 44 Liu, R.Q., Qian, Z., Trevathan, E., Chang, J.J., Zelicoff, A., Hao, Y.T., et al. Poor sleep quality associated with high risk of hypertension and elevated blood pressure in China: results from a large population-based study. Hypertens Res 39:1 (2016), 54–59.
45. 45 Bansil, P., Kuklina, E.V., Merritt, R.K., Yoon, P.W., Associations between sleep disorders, sleep duration, quality of sleep, and hypertension: results from the National Health and Nutrition Examination Survey, 2005 to 2008. J Clin Hypertens (Greenwich) 13:10 (2011), 739–743.
46. 46 Loredo, J.S., Ancoli-Israel, S., Dimsdale, J.E., Sleep quality and blood pressure dipping in obstructive sleep apnea. Am J Hypertens 14:9 Pt 1 (2001), 887–892.
47. 47 Loredo, J.S., Nelesen, R., Ancoli-Israel, S., Dimsdale, J.E., Sleep quality and blood pressure dipping in normal adults. Sleep 27:6 (2004), 1097–1103.
48. 48 Sherwood, A., Routledge, F.S., Wohlgemuth, W.K., Hinderliter, A.L., Kuhn, C.M., Blumenthal, J.A., Blood pressure dipping: ethnicity, sleep quality, and sympathetic nervous system activity. Am J Hypertens 24:9 (2011), 982–988.
49. 49 American Psychiatric Association, American Psychiatric Association. DSM-5 Task Force. Diagnostic and statistical manual of mental disorders: DSM-5. 5th ed., 2013, American Psychiatric Association, Washington, D.C.
50. 50 Medicine AAoS. The International Classification of Sleep Disorders. 3rd ed., 2014, American Academy of Sleep Medicine, Darien, IL.
51. 51 Vgontzas, A.N., Liao, D., Bixler, E.O., Chrousos, G.P., Vela-Bueno, A., Insomnia with objective short sleep duration is associated with a high risk for hypertension. Sleep 32:4 (2009), 491–497.
52. 52 Budhiraja, R., Roth, T., Hudgel, D.W., Budhiraja, P., Drake, C.L., Prevalence and polysomnographic correlates of insomnia comorbid with medical disorders. Sleep 34:7 (2011), 859–867.
53. 53 Fernandez-Mendoza, J., Vgontzas, A.N., Liao, D., Shaffer, M.L., Vela-Bueno, A., Basta, M., et al. Insomnia with objective short sleep duration and incident hypertension: the Penn State Cohort. Hypertension 60:4 (2012), 929–935.
54. 54 Vozoris, N.T., Insomnia symptom frequency and hypertension risk: a population-based study. J Clin Psychiatry 75:6 (2014), 616–623.
55. 55 Phillips, B., Buzkova, P., Enright, P., Cardiovascular Health Study Research Group. Insomnia did not predict incident hypertension in older adults in the cardiovascular health study. Sleep 32:1 (2009), 65–72.
56. 56 Phillips, B., Mannino, D.M., Do insomnia complaints cause hypertension or cardiovascular disease?. J Clin Sleep Med 3:5 (2007), 489–494.
57. 57 Meng, L., Zheng, Y., Hui, R., The relationship of sleep duration and insomnia to risk of hypertension incidence: a meta-analysis of prospective cohort studies. Hypertens Res 36:11 (2013), 985–995.
58. 58 Lauderdale, D.S., Knutson, K.L., Yan, L.L., Liu, K., Rathouz, P.J., Self-reported and measured sleep duration: how similar are they?. Epidemiology 19:6 (2008), 838–845.
59. 59 Lichstein, K.L., Justin Thomas, S., Woosley, J.A., Geyer, J.D., Co-occurring insomnia and obstructive sleep apnea. Sleep Med 14:9 (2013), 824–829.
60. 60 Vgontzas, A.N., Bixler, E.O., Lin, H.M., Prolo, P., Mastorakos, G., Vela-Bueno, A., et al. Chronic insomnia is associated with nyctohemeral activation of the hypothalamic-pituitary-adrenal axis: clinical implications. J Clin Endocrinol Metab 86:8 (2001), 3787–3794.
61. 61 Li, Y., Vgontzas, A.N., Fernandez-Mendoza, J., Bixler, E.O., Sun, Y., Zhou, J., et al. Insomnia with physiological hyperarousal is associated with hypertension. Hypertension 65:3 (2015), 644–650.
62. 62 Dassi, S., Balsama, M., Guzzetti, S., Ponti, G.B., Magni, L., Pagani, M., et al. Twenty-four-hour power spectral analysis of heart rate variability and of arterial pressure values in normotensive and hypertensive subjects. J Hypertens Suppl 9:6 (1991), S72–S73.
63. 63 Dudenbostel, T., Acelajado, M.C., Pisoni, R., Li, P., Oparil, S., Calhoun, D.A., Refractory hypertension: evidence of heightened sympathetic activity as a cause of antihypertensive treatment failure. Hypertension 66:1 (2015), 126–133.
64. 64 Drake, C.L., Pillai, V., Roth, T., Stress and sleep reactivity: a prospective investigation of the stress-diathesis model of insomnia. Sleep 37:8 (2014), 1295–1304.
65. 65 Spielman, A.J., Caruso, L.S., Glovinsky, P.B., A behavioral perspective on insomnia treatment. Psychiatr Clin North Am 10:4 (1987), 541–553.
66. 66 Buysse, D.J., Germain, A., Hall, M., Monk, T.H., Nofzinger, E.A., A neurobiological model of insomnia. Drug Discov Today Dis Models 8:4 (2011), 129–137.
67. 67 Fava, C., Dorigoni, S., Dalle Vedove, F., Danese, E., Montagnana, M., Guidi, G.C., et al. Effect of CPAP on blood pressure in patients with OSA/hypopnea a systematic review and meta-analysis. Chest 145:4 (2014), 762–771.